(Q36568458)

15 August 2017

1 reference

title

Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections (English)

1 reference

15 August 2017

1 reference

Safdar A

1

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

Bone Marrow Transplantation

15 August 2017

published in

1 reference

15 August 2017

volume

38

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

327-337

1 reference

Infectious morbidity in critically ill patients with cancer

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Listeriosis in recipients of allogeneic blood and marrow transplantation: thirteen year review of disease characteristics, treatment outcomes and a new association with human cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Uncommon opportunistic fungi: new nosocomial threats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Clinical significance of non-Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993-2001).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Invasive pulmonary aspergillosis: frequency and meaning of the "hypodense sign" on unenhanced CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Infectious pulmonary nodules in immunocompromised patients: usefulness of computed tomography in predicting their etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Crescent sign in invasive pulmonary aspergillosis: frequency and related CT and clinical factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Aspergillosis case-fatality rate: systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Combination antifungal therapy for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Posaconazole as salvage therapy for zygomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Involvement of toll-like receptor 2 in experimental invasive pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Immunosuppressive effects of CCL17 on pulmonary antifungal responses during pulmonary invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Distinct CD4+-T-cell responses to live and heat-inactivated Aspergillus fumigatus conidia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Glucocorticoids and invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

White cell transfusions born again

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Neutrophil extracellular traps kill bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, an

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Inhibitor kappaB and nuclear factor kappaB in granulocyte-macrophage colony-stimulating factor antagonism of dexamethasone suppression of the macrophage response to Aspergillus fumigatus conidia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Regulation by granulocyte-macrophage colony-stimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Strategies to reduce transplant-related mortality after allogeneic stem cell transplantation in elderly patients: Comparison of reduced-intensity conditioning and unmanipulated peripheral blood stem cells vs a myeloablative regimen and CD34+ cell se

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Haematopoietic stem cell transplantation with non-myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Involvement of secreted Aspergillus fumigatus proteases in disruption of the actin fiber cytoskeleton and loss of focal adhesion sites in infected A549 lung pneumocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Dendritic Cells Transport Conidia and Hyphae of Aspergillus fumigatus from the Airways to the Draining Lymph Nodes and Initiate Disparate Th Responses to the Fungus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

7 January 2021

Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

7 January 2021

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

7 January 2021

Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

7 January 2021

Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

7 January 2021

Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

7 January 2021

Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

7 January 2021

Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

7 January 2021

Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

7 January 2021

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

7 January 2021

Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

7 January 2021

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

7 January 2021

Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705439

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705439

1 reference

15 August 2017

1 reference